Rating

	My Rating: 3 ratings 5 stars (3) 4 stars (0) 3 stars (0) 2 stars (0) 1 stars (0)

Email

	Email this page to a friend Friend's Email: Your Name: Your Email: Enter the code shown: Submitting Send Email

References

1. Psota TL, Gebauer SK, Kris-Etherton P. Dietary omega-3 fatty acid intake and cardiovascular risk. Am J Cardiol. 2006;98:3i-18i.

2. Jacobson TA. Secondary prevention of coronary artery disease with omega-3 fatty acids. Am J Cardiol. 2006;98:61i-70i.

3. Lee JH, O'Keefe JH, Lavie CJ, Harris WS. Omega-3 fatty acids: cardiovascular benefits, sources and sustainability. Nature reviews. Cardiology. 2009;6:753-8.

4. Lavie CJ, Milani RV, Mehra MR, Ventura HO. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. Journal of the American College of Cardiology. 2009;54:585-94.

5. Roth EM, Harris WS. Fish oil for primary and secondary prevention of coronary heart disease. Curr Atheroscler Rep. 2010;12:66-72.

6. Weitz D, Weintraub H, Fisher E, Schwartzbard AZ. Fish oil for the treatment of cardiovascular disease. Cardiol Rev. 2010;18:258-63.

7. McGowan MP, Proulx S. Nutritional supplements and serum lipids: does anything work? Current atherosclerosis reports. 2009;11:470-6.

8. Stalenhoef AF, de Graaf J, Wittekoek ME, Bredie SJ, Demacker PN, Kastelein JJ. The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia. Atherosclerosis. 2000;153:129-38.

9. Bays H. Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids. Am J Cardiol. 2006;98:71i-76i.

10. Omega-3 polyunsaturated fatty acids (Omacor) for hypertriglyceridemia. Med Lett Drugs Ther. 2005;47:91.

11. Dimitrow PP, Jawien M. Pleiotropic, Cardioprotective Effects of Omega-3 Polyunsaturated Fatty Acids. Mini Rev Med Chem. 2009.

12. Nambi V, Ballantyne CM. Combination therapy with statins and omega-3 fatty acids. Am J Cardiol. 2006;98:34i-38i.

Continued on next page >